Daniele Focosi to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Daniele Focosi has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.158
-
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline. MAbs. 2020 Jan-Dec; 12(1):1854149.
Score: 0.158
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.